Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

348
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
348
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

313
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
313
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

1.3K
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

1.6K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.6K
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

494
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
494
Tonsillitis II: Management01:26

Tonsillitis II: Management

541
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
541

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Where are we in the diagnosis and treatment of hirsutism? A narrative review.

Reviews in endocrine & metabolic disorders·2026
Same author

Models of care on the management of women with polycystic ovary syndrome: A multicentre study.

Endocrine·2026
Same author

Investigating the relationship between thyroid replacement therapy goals status and quality of life in patients with primary hypothyroidism.

Endocrine·2026
Same author

Approach to the Patient With Traumatic Brain Injury-induced Pituitary Dysfunction.

The Journal of clinical endocrinology and metabolism·2026
Same author

Oral and gut microbiota after acromegaly treatment: prospective assessment and insights from machine learning.

Pituitary·2025
Same author

The frequency of polycystic ovary syndrome in women with prediabetes compared with normoglycemic women.

Frontiers in endocrinology·2025

Related Experiment Video

Updated: Mar 24, 2026

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
10:52

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis

Published on: December 17, 2010

15.1K

The management of hypophysitis.

Zuleyha Karaca1, Fahrettin Kelestimur

  • 1Erciyes University Medical School, Department of Endocrinology, Kayseri, Turkey - fktimur@erciyes.edu.tr.

Minerva Endocrinologica
|March 11, 2016
PubMed
Summary

This review discusses primary hypophysitis, an autoimmune pituitary gland inflammation. Treatment focuses on managing symptoms, hormone replacement, and considering surgery or medications like glucocorticoids for severe cases.

Area of Science:

  • Endocrinology
  • Immunology
  • Neurology

Background:

  • Hypophysitis is an autoimmune inflammatory condition affecting the pituitary gland.
  • It can be categorized as primary or secondary, with this review focusing on primary hypophysitis.
  • Management strategies aim to alleviate pituitary mass effects and hormonal deficiencies.

Purpose of the Study:

  • To review and discuss the treatment approaches for primary hypophysitis across various histological subtypes.
  • To provide insights into the current management strategies for this autoimmune pituitary disorder.

Main Methods:

  • Literature review focusing on treatment modalities for primary hypophysitis.
  • Analysis of symptomatic management, hormone replacement, surgical interventions, and pharmacological treatments.

More Related Videos

Induction of Experimental Autoimmune Hypophysitis in SJL Mice
10:38

Induction of Experimental Autoimmune Hypophysitis in SJL Mice

Published on: December 17, 2010

12.0K
Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
02:22

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection

Published on: April 12, 2024

1.1K

Related Experiment Videos

Last Updated: Mar 24, 2026

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
10:52

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis

Published on: December 17, 2010

15.1K
Induction of Experimental Autoimmune Hypophysitis in SJL Mice
10:38

Induction of Experimental Autoimmune Hypophysitis in SJL Mice

Published on: December 17, 2010

12.0K
Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
02:22

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection

Published on: April 12, 2024

1.1K
  • Evaluation of the role of glucocorticoids, other immunosuppressants, and radiotherapy.

    • Main Results:

    • Symptomatic management, including hormone replacement, is a primary approach.
    • Glucocorticoids are the most common initial treatment, offering anti-inflammatory benefits and potential functional recovery.
    • Surgery is reserved for severe compressive symptoms or diagnostic uncertainty; other immunotherapies are considered for refractory cases.

    Conclusions:

    • Treatment for primary hypophysitis is largely symptomatic, focusing on mass reduction and hormone replacement.
    • Glucocorticoids are a cornerstone of treatment, though optimal protocols are debated.
    • A stepwise approach involving observation, hormone replacement, surgery, and advanced immunotherapies guides management based on disease severity and presentation.